Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
3 "Eun-Mi Son"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Clinical and Prognostic Significances of Cytokeratin 19 and KIT Expression in Surgically Resectable Pancreatic Neuroendocrine Tumors
Eun-Mi Son, Joo Young Kim, Soyeon An, Ki-Byung Song, Song Cheol Kim, Eunsil Yu, Seung-Mo Hong
J Pathol Transl Med. 2015;49(1):30-36.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.23
  • 10,731 View
  • 101 Download
  • 19 Web of Science
  • 18 Crossref
AbstractAbstract PDF
Background
Pancreatic neuroendocrine tumors (PanNETs) are malignant endocrine neoplasms that present diverse clinical behaviors. Therefore, identification of biomarkers of PanNETs is important for stratification of the prognosis of PanNET patients. Recently, cytokeratin 19 (CK19) and KIT expression were reported to have prognostic significance in PanNET patients. Methods: To identify their prognostic significance, CK19 and KIT protein expression were assessed in 182 surgically resected PanNETs and compared with clinicopathologic factors. Results: Of 182 PanNETs cases, CK19 and KIT expression was noted in 97 (53.3%) and 16 (8.8%) cases, respectively. PanNET patients with CK19 expression had larger tumors (p=.006), higher World Health Organization (WHO) grade (p=.002) and pT classification (p<.001), increased distant metastasis (p=.004), and lymphovascular (p=.012) and perineural (p=.019) invasion. Similarly, those with KIT expression had larger tumors (p=.030), higher WHO grade (p=.001), advanced pT classification (p<.001), distant metastasis (p=.001), and lymphovascular invasion (p=.014). The 5-year survival rate for PanNET patients with KIT expression was significantly lower (62%) than that of patients without KIT expression (77%, p=.011), as determined by univariate but not by multivariate analyses. Conclusions: CK19 and KIT expression correlate with higher metastatic potential and advanced disease stage, and KIT expression is associated with worse survival in PanNET patients.

Citations

Citations to this article as recorded by  
  • Expression profiles of cadherin 17 and claudin 18.2 in comparison with peptide hormonal expression in pancreatic neuroendocrine tumours: Implications for targeted immunotherapy
    Kahoko Maeda, Takeshi Uehara, Waki Hosoda, Yasuhiro Kuraishi, Hiroyoshi Ota
    Pathology - Research and Practice.2024; 262: 155537.     CrossRef
  • Combined Infiltrative Macroscopic Growth Pattern and Infiltrative Microscopic Tumor Border Status Is a Novel Surrogate Marker of Poor Prognosis in Patients With Pancreatic Neuroendocrine Tumor
    Bokyung Ahn, Joo Young Kim, Seung-Mo Hong
    Archives of Pathology & Laboratory Medicine.2023; 147(1): 100.     CrossRef
  • Tumor-associated nonmyelinating Schwann cell–expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion
    Chengcao Sun, Youqiong Ye, Zhi Tan, Yuan Liu, Yajuan Li, Wei Hu, Ke Liang, Sergey D. Egranov, Lisa Angela Huang, Zhao Zhang, Yaohua Zhang, Jun Yao, Tina K. Nguyen, Zilong Zhao, Andrew Wu, Jeffrey R. Marks, Abigail S. Caudle, Aysegul A. Sahin, Jianjun Gao,
    Science Advances.2023;[Epub]     CrossRef
  • Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors
    Anne Menz, Rifka Bauer, Martina Kluth, Clara Marie von Bargen, Natalia Gorbokon, Florian Viehweger, Maximilian Lennartz, Cosima Völkl, Christoph Fraune, Ria Uhlig, Claudia Hube-Magg, Noémi De Wispelaere, Sarah Minner, Guido Sauter, Simon Kind, Ronald Simo
    Human Pathology.2021; 115: 19.     CrossRef
  • The molecular biology of pancreatic neuroendocrine neoplasms: Challenges and translational opportunities
    Kate Young, Naureen Starling, Anguraj Sadanandam
    Seminars in Cancer Biology.2020; 61: 132.     CrossRef
  • Pancreatic acinar cell carcinomas and mixed acinar-neuroendocrine carcinomas are more clinically aggressive than grade 1 pancreatic neuroendocrine tumours
    Joo Young Kim, Jacqueline A. Brosnan-Cashman, Jiyoon Kim, Soyeon An, Kyoung-Bun Lee, Haeryoung Kim, Do Youn Park, Kee-Taek Jang, Young-Ha Oh, Ralph H. Hruban, Christopher M. Heaphy, Seung-Mo Hong
    Pathology.2020; 52(3): 336.     CrossRef
  • Morphologic Variants of Pancreatic Neuroendocrine Tumors: Clinicopathologic Analysis and Prognostic Stratification
    Yue Xue, Michelle D. Reid, Burcin Pehlivanoglu, Rebecca C. Obeng, Hongmei Jiang, Bahar Memis, Shu K. Lui, Juan Sarmiento, David Kooby, Shishir K. Maithel, Bassel El-Rayes, Olca Basturk, Volkan Adsay
    Endocrine Pathology.2020; 31(3): 239.     CrossRef
  • Histological grades and prognostic markers of well-differentiated pancreatic neuroendocrine tumor (WDPNET)
    Yongchao Li, Daniel Rowan, Claire P. Williamson, Meiyun Fan, Ali G. Saad, Lizhi Zhang
    Journal of Pancreatology.2020; 3(4): 188.     CrossRef
  • Clinical and histopathologic prognostic implications of the expression of cytokeratins 8, 10, 13, 14, 16, 18 and 19 in oral and oropharyngeal squamous cell carcinoma
    Rima A. Safadi, Niveen I. Abdullah, Rolla F. Alaaraj, Dima H. Bader, Darshan D. Divakar, Abed A. Hamasha, Maher A. Sughayer
    Archives of Oral Biology.2019; 99: 1.     CrossRef
  • Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies
    Lingaku Lee, Tetsuhide Ito, Robert T Jensen
    Expert Review of Anticancer Therapy.2019; 19(12): 1029.     CrossRef
  • Carbonic anhydrase 9 expression in well-differentiated pancreatic neuroendocrine neoplasms might be associated with aggressive behavior and poor survival
    Joo Young Kim, Sang Hwa Lee, Soyeon An, Sung Joo Kim, You-Na Sung, Ki-Byung Song, Dae Wook Hwang, Song Cheol Kim, Seung-Mo Hong
    Virchows Archiv.2018; 472(5): 739.     CrossRef
  • CD133 expression in well-differentiated pancreatic neuroendocrine tumors: a potential predictor of progressive clinical courses
    Yasuhiro Sakai, Seung-Mo Hong, Soyeon An, Joo Young Kim, Denis Corbeil, Jana Karbanová, Kyoko Otani, Kohei Fujikura, Ki-Byung Song, Song Cheol Kim, Masayuki Akita, Yoshihide Nanno, Hirochika Toyama, Takumi Fukumoto, Yonson Ku, Takanori Hirose, Tomoo Itoh,
    Human Pathology.2017; 61: 148.     CrossRef
  • Prognostic and predictive biomarkers in neuroendocrine tumours
    David L. Chan, Stephen J. Clarke, Connie I. Diakos, Paul J. Roach, Dale L. Bailey, Simron Singh, Nick Pavlakis
    Critical Reviews in Oncology/Hematology.2017; 113: 268.     CrossRef
  • Loss of Progesterone Receptor Expression Is an Early Tumorigenesis Event Associated with Tumor Progression and Shorter Survival in Pancreatic Neuroendocrine Tumor Patients
    Sung Joo Kim, Soyeon An, Jae Hoon Lee, Joo Young Kim, Ki-Byung Song, Dae Wook Hwang, Song Cheol Kim, Eunsil Yu, Seung-Mo Hong
    Journal of Pathology and Translational Medicine.2017; 51(4): 388.     CrossRef
  • Prognostic significance of cytokeratin 19 expression in pancreatic neuroendocrine tumor: A meta-analysis
    Dong Cen, Jiang Chen, Zheyong Li, Jie Zhao, Xiujun Cai, Aamir Ahmad
    PLOS ONE.2017; 12(11): e0187588.     CrossRef
  • A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases
    Liangtao Ye, Huilin Ye, Quanbo Zhou, Zhihua Li, Qing Lin, Langping Tan, Wenchao Gao, Zhiqiang Fu, Shangyou Zheng, Rufu Chen
    International Journal of Surgery.2016; 29: 108.     CrossRef
  • Correlating and Combining Genomic and Proteomic Assessment withIn VivoMolecular Functional Imaging: Will This Be the Future Roadmap for Personalized Cancer Management?
    Bhakti Basu, Sandip Basu
    Cancer Biotherapy and Radiopharmaceuticals.2016; 31(3): 75.     CrossRef
  • Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts
    Joo Young Kim, Seung-Mo Hong
    Archives of Pathology & Laboratory Medicine.2016; 140(5): 437.     CrossRef
Brief Case Report
Mixed Carcinoid-Mucinous Adenocarcinoma Arising in Mature Teratoma of Mesentery
Su-Jin Shin, Eun-Mi Son, Chang Ohk Sung, Kyu-Rae Kim
J Pathol Transl Med. 2015;49(1):61-65.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.09.17
  • 10,377 View
  • 93 Download
  • 4 Web of Science
  • 5 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Prostate Type Malignancies Arising in Ovarian Teratomas – A Report of Two Patients
    Shreeya Indulkar, Andres Matoso
    International Journal of Surgical Pathology.2024;[Epub]     CrossRef
  • Mixed neuroendocrine/Non-neuroendocrine neoplasm (MiNEN) of gastrointestinal lineage arising in an ovarian mature cystic teratoma
    Sandhyarani Dasaraju, Khalid Amin, Molly E. Klein, Colleen Rivard, Jordan Mattson, Sarah Davidson, Mahmoud A. Khalifa
    Gynecologic Oncology Reports.2022; 44: 101099.     CrossRef
  • A Case of Mature Cystic Teratoma of the Mesentery
    Ryogo Ito, Motoi Yoshihara, Atsuki Arimoto, Taro Aoba, Yoshihisa Shibata, Kazuhiro Hiramatsu, Takehito Kato
    The Japanese Journal of Gastroenterological Surgery.2021; 54(5): 344.     CrossRef
  • Synchronous colonic adenocarcinoma and well-differentiated neuroendocrine tumor arising in a mature cystic teratoma of ovary — rare presentation in a postmenopausal woman with literature review
    Pavithra Ayyanar, Jasmina Begum, Subhashree Rout, Pritinanda Mishra
    Indian Journal of Pathology and Microbiology.2021; 64(2): 385.     CrossRef
  • Primary ovarian mixed strumal and mucinous carcinoid arising in an ovarian mature cystic teratoma
    Na Rae Kim, Seung Yeon Ha, Jin Woo Shin, Soyi Lim, Chan Yong Park, Hyun Yee Cho
    Journal of Obstetrics and Gynaecology Research.2016; 42(2): 211.     CrossRef
Original Article
Primary Squamous Cell Carcinoma of the Upper Genital Tract: Utility of p16INK4a Expression and HPV DNA Status in its Differential Diagnosis from Extended Cervical Squamous Cell Carcinoma
Su Hyun Yoo, Eun-Mi Son, Chang Okh Sung, Kyu-Rae Kim
Korean J Pathol. 2013;47(6):549-556.   Published online December 24, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.6.549
  • 6,940 View
  • 64 Download
  • 5 Crossref
AbstractAbstract PDF
Background

Primary squamous cell carcinoma (SCC) of the upper genital tract, including the endometrium, fallopian tubes, and ovaries, is extremely rare. It must be distinguished from the mucosal extension of primary cervical SCC because determination of the primary tumor site is important for tumor staging. However, patients with SCC of the fallopian tubes or ovarian surface have often undergone prior hysterectomy with inadequate examination of the cervix, making it difficult to determine the primary site.

Methods

We compared histologic findings, p16INK4a expression, and human papillomavirus (HPV) DNA status in four patients with primary SCC of the upper genital tract and five patients with primary cervical SCC extending to the mucosa of the upper genital tract.

Results

All five SCCs of cervical origin showed strong expression of p16INK4a, whereas all four SCCs of the upper genital tract were negative, although one showed weak focal staining. Three of the five cervical SCCs were positive for HPV16 DNA, whereas all four primary SCCs of the upper genital tract were negative for HPV DNA.

Conclusions

Although a thorough histological examination is important, immunonegativity for p16INK4a and negative for HPV DNA may be useful adjuncts in determining primary SCCs of the upper genital tract.

Citations

Citations to this article as recorded by  
  • PAX8 Positivity, Abnormal p53 Expression, and p16 Negativity in a Primary Endometrial Squamous Cell Carcinoma: A Case Report and Review of the Literature
    Daniela Fanni, Michele Peiretti, Valerio Mais, Elena Massa, Clara Gerosa, Francesca Ledda, Maria Luisa Fais, Gavino Faa, Stefano Angioni
    International Journal of Gynecological Pathology.2022; 41(4): 431.     CrossRef
  • Molecular Analysis of HPV-independent Primary Endometrial Squamous Cell Carcinoma Reveals TP53 and CDKN2A Comutations
    Mark R. Hopkins, Doreen N. Palsgrove, Brigitte M. Ronnett, Russell Vang, Jeffrey Lin, Tricia A. Murdock
    American Journal of Surgical Pathology.2022; 46(12): 1611.     CrossRef
  • Primary squamous cell carcinoma of the endometrium—Case report with cytological characteristics in direct and indirect endometrial samples
    Sanda Rajhvajn, Ana Barišić, Lada Škopljanac‐Mačina, Danijela Jurič, Vesna Mahovlić
    Cytopathology.2021; 32(6): 823.     CrossRef
  • Überraschung in der Abradatdiagnostik
    U. Kellner, A. Kellner, U. Cirkel
    Der Pathologe.2015; 36(3): 317.     CrossRef
  • Retropharyngeal Lymph Node Metastasis in 54 Patients with Oropharyngeal Squamous Cell Carcinoma Who Underwent Surgery-Based Treatment
    Eun-Jae Chung, Go-Woon Kim, Bum-Ki Cho, Sung-Jin Cho, Dae-Young Yoon, Young-Soo Rho
    Annals of Surgical Oncology.2015; 22(9): 3049.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP